CHRIST CHURCH, Barbados, Oct. 16, 2025 (GLOBE NEWSWIRE) — Comfort Colors®, the trusted name in high-quality, soft, ring-spun cotton, is celebrating 50 years of spreading good vibes by taking its laid-back lifestyle to one of the South’s most spirited stages. On October 18, 2025, the brand will host a 50th Anniversary Game Day Pop-Up outside Sanford Stadium during the University of Georgia vs. Ole Miss matchup, creating an immersive experience that celebrates comfort, color and community. As part of the 50 Years of Spreading Good Vibes campaign, the activation connects Comfort Colors® with its roots in campus culture, where generations first embraced the brand’s relaxed style and worn-in softness, while welcoming a new wave of fans. Visitors can grab free branded treats from the Comfort Colors® Food Truck, browse the expanded lifestyle...

SOUTH SAN FRANCISCO, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that the United States Adopted Names (USAN) Council has adopted pevifoscorvir sodium as the nonproprietary (generic) name for ALG-000184, under investigation for the treatment of chronic hepatitis B virus (HBV) infection. The USAN, consisting of members from the Food and Drug Administration (FDA), American Medical Association (AMA), United States Pharmacopeia (USP) and the American Pharmacists Association (APhA), is responsible for developing simple, informative and unique nonproprietary (generic) drug names. “The adoption of pevifoscorvir sodium, or pevy, marks the first...

Fluent to Attend Rebuy Momentum Innovation Summit NYC on October 21 NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) — Fluent, Inc. (NASDAQ: FLNT), a leading provider of commerce media solutions, and Rebuy Engine, the leading ecommerce personalization platform for Shopify brands, today shared an update on the continued success of their strategic partnership, Rebuy Monetize powered by Fluent, which launched in May 2025 (originally as Rebuy Ads powered by Fluent). Rebuy and Fluent will showcase new opportunities for merchants at Rebuy Momentum Innovation Summit NYC on October 21, 2025. Accelerating Adoption and Revenue Rebuy Monetize powered by Fluent delivers personalized, non-competing offers that complement each brand’s experience, turning every checkout into an opportunity to delight customers and drive measurable incremental revenue....

EATONTOWN, N.J., Oct. 16, 2025 (GLOBE NEWSWIRE) — {{DATELINECITY_DATE_GLOBENEWSWIRE_BUG}}Climb Global Solutions, Inc. (NASDAQ:CLMB) (“Climb” or the “Company”), a value-added global IT channel company providing unique sales and distribution solutions for innovative technology vendors, will host a conference call on Thursday, October 30, 2025 at 8:30 a.m. Eastern time to discuss its financial results for the third quarter ended September 30, 2025. The Company’s results will be reported in a press release prior to the call. Climb’s management will host the conference call, followed by a question-and-answer period. Interested parties may submit questions to the Company prior to the call by emailing CLMB@elevate-ir.com. Date: Thursday, October 30, 2025Time: 8:30 a.m. Eastern timeToll-free dial-in number: (800) 445-7795International...

VANCOUVER, British Columbia, Oct. 16, 2025 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath devices is pleased to report the delivery of its BreathLogix technology to an oil and gas transportation services company located in northern Alberta, Canada. The BreathLogix system is designed for rapid, unmanned testing and is tailored for industries where safety is critical, including mining, oil and gas, industrial operations, trucking, warehousing, and maritime sectors. This adoption underscores Cannabix’s commitment to providing innovative solutions that help reduce risk and promote a culture of safety.Figure 1. BreathLogix Alcohol device available with contactless and straw modes for rapid workplace pre-accessalcohol...

HAUPPAUGE, N.Y., Oct. 16, 2025 (GLOBE NEWSWIRE) — AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer and manufacturer of advanced signal-processing components for satellite, Public and Private 5G, and other communications networks, including complete 5G/6G systems, and a global distributor of IC packaging solutions, today announced its participation in the upcoming 2025 Maxim Growth Summit, taking place from October 22nd to 23rd at The Hard Rock Hotel NYC. AmpliTech Group will be meeting with institutional investors in a one-on-one format, and senior Maxim analysts during the event. This prestigious event brings together industry leaders, innovators, and premier institutions to explore the latest trends and advancements across several industries. Keynote speakers include Larry Kudlow (Broadcaster, Fox News) and Christopher...

Action Underscores Board Confidence Following Triple-Digit Sales Growth and Expanding Market Demand for AI Security Solutions PALO ALTO, CA, Oct. 16, 2025 (GLOBE NEWSWIRE) — Cloudastructure, Inc. (Nasdaq: CSAI) (“we,” “us,” “our,” “Cloudastructure” or the “Company”), a recognized leader in AI Surveillance and Remote Guarding, today announced that its Board of Directors (the “Board”) authorized a share repurchase program under which the Company may repurchase up to $5 million of its outstanding shares of common stock in the open market, in accordance with all applicable securities laws and regulations, including Rule 10b-18 of the Securities Exchange Act of 1934, as amended. The Company’s decision to repurchase its shares, as well as the timing of such repurchases, will depend on a variety of factors that include ongoing assessments...

Odyssey Medical Devices, Inc., a subsidiary of Odyssey Health Inc., to acquire exclusive global marketing and distribution rights for the BreastCheck® LAS VEGAS, Oct. 16, 2025 (GLOBE NEWSWIRE) — Odyssey Health, Inc. (OTCQB: ODYY), a medical device company with a focus in life-saving medical solutions today announced that the company has signed a sub-licensing agreement for exclusive, worldwide rights to the BreastCheck®, a non-invasive test for breast abnormalities. The definitive agreement, managed through its subsidiary Odyssey Medical Devices, Inc., is subject to certain closing conditions. The BreastCheck® test can be done at home and takes just 15 minutes. The results are immediate and BreastCheck® has been proven to be a reliable guide in the first stage identification of potential breast abnormalities. While BreastCheck®...

Mr. Kelly is a proven strategic CFO with significant financial, operational and commercialization leadership experience VANCOUVER, British Columbia and BOSTON, Oct. 16, 2025 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need, today announced the appointment of Tucker Kelly as Chief Financial Officer (CFO) and member of the Xenon senior executive team. Mr. Kelly is a proven executive who brings extensive strategic and commercial finance expertise, both in the U.S. and internationally, that will help the Company prepare for the anticipated commercialization of its lead candidate, azetukalner. Azetukalner is currently being studied broadly in three Phase...

First U.S. Based Medical Meeting Presence Post-FDA Clearance Will Allow the Company to Commercially Engage Future Potential Users of the LIBERTY® System Company Completes the Recruitment of its Commercial Leadership Team as it Remains On Track to Commence the Launch of The LIBERTY® SystemDuring Q4 of This Year HINGHAM, Mass., Oct. 16, 2025 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), developer and distributer of the innovative LIBERTY® Endovascular Robotic System, today announced that it will be exhibiting the LIBERTY® System at the upcoming Symposium on Clinical Interventional Oncology annual meeting (CIO), being held in Miami, FL on October 17-19. The annual symposium presents practical education on the latest treatments in the rapidly expanding field of interventional oncology and represents the first medical meeting...